CY1124192T1 - Συσκευες για την in vivo χορηγηση φαρμακων - Google Patents
Συσκευες για την in vivo χορηγηση φαρμακωνInfo
- Publication number
- CY1124192T1 CY1124192T1 CY20211100479T CY211100479T CY1124192T1 CY 1124192 T1 CY1124192 T1 CY 1124192T1 CY 20211100479 T CY20211100479 T CY 20211100479T CY 211100479 T CY211100479 T CY 211100479T CY 1124192 T1 CY1124192 T1 CY 1124192T1
- Authority
- CY
- Cyprus
- Prior art keywords
- drug
- reservoir
- drug delivery
- devices
- methods
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 abstract 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 230000001272 neurogenic effect Effects 0.000 abstract 1
- 208000020629 overactive bladder Diseases 0.000 abstract 1
- 208000020431 spinal cord injury Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/04—General characteristics of the apparatus implanted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1085—Bladder
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762453333P | 2017-02-01 | 2017-02-01 | |
| US201762480744P | 2017-04-03 | 2017-04-03 | |
| PCT/US2018/016463 WO2018144738A1 (en) | 2017-02-01 | 2018-02-01 | In vivo drug delivery devices and methods for drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124192T1 true CY1124192T1 (el) | 2022-05-27 |
Family
ID=61231348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100479T CY1124192T1 (el) | 2017-02-01 | 2021-06-01 | Συσκευες για την in vivo χορηγηση φαρμακων |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US11020575B2 (https=) |
| EP (1) | EP3432970B1 (https=) |
| JP (2) | JP7366748B2 (https=) |
| KR (1) | KR102564771B1 (https=) |
| CN (1) | CN110418658A (https=) |
| AU (2) | AU2018217094B2 (https=) |
| CY (1) | CY1124192T1 (https=) |
| DK (1) | DK3432970T3 (https=) |
| ES (1) | ES2873084T3 (https=) |
| HR (1) | HRP20210571T1 (https=) |
| HU (1) | HUE054587T2 (https=) |
| IL (1) | IL268385B (https=) |
| LT (1) | LT3432970T (https=) |
| MX (2) | MX2019009080A (https=) |
| PL (1) | PL3432970T3 (https=) |
| PT (1) | PT3432970T (https=) |
| RS (1) | RS62459B1 (https=) |
| RU (1) | RU2759868C2 (https=) |
| SG (1) | SG11201907033SA (https=) |
| SI (1) | SI3432970T1 (https=) |
| SM (1) | SMT202100310T1 (https=) |
| WO (1) | WO2018144738A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019178134A1 (en) * | 2018-03-13 | 2019-09-19 | Semma Therapeutics, Inc. | Implantation devices, system, and methods |
| CN112839653A (zh) * | 2018-08-01 | 2021-05-25 | 塔里斯生物医药公司 | 使用曲司氯铵治疗膀胱过度活动症的方法 |
| CN109765118B (zh) * | 2018-12-22 | 2021-09-17 | 临沂协润工贸有限公司 | 一种纺织品韧性测试仪 |
| KR20220146361A (ko) * | 2021-04-23 | 2022-11-01 | 김승범 | 과민성 방광 치료 장치 |
| CN113274624B (zh) * | 2021-07-06 | 2023-05-12 | 中南大学湘雅医院 | 一种可视化尿道扩张术后治疗仪 |
| EP4710986A2 (en) | 2021-12-21 | 2026-03-18 | TARIS Biomedical LLC | Urinary placement catheter for intravesical devices |
| CN119072311A (zh) | 2022-02-18 | 2024-12-03 | 塔里斯生物医药公司 | 用于膀胱内施用的厄达替尼制剂和渗透系统 |
| WO2024092159A1 (en) | 2022-10-28 | 2024-05-02 | Taris Biomedical Llc | Methods of treating bladder cancer with gemcitabine |
| JP2026506041A (ja) | 2023-02-17 | 2026-02-20 | タリス バイオメディカル エルエルシー | 膀胱がんの治療における使用のための膀胱内投与のためのエルダフィチニブ |
| WO2024215682A1 (en) | 2023-04-10 | 2024-10-17 | Taris Biomedical Llc | Gemcitabine for use in methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guerin therapy |
| WO2025076007A1 (en) | 2023-10-02 | 2025-04-10 | Taris Biomedical Llc | Methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guérin therapy |
| WO2026058217A1 (en) | 2024-09-13 | 2026-03-19 | Taris Biomedical Llc | Intravesical gemcitabine for use in treating bacillus calmette-guérin (bcg)-naive high-risk non-muscle invasive bladder cancer (hr-nmibc) |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4210139A (en) | 1979-01-17 | 1980-07-01 | Alza Corporation | Osmotic device with compartment for governing concentration of agent dispensed from device |
| US4657536A (en) | 1979-04-13 | 1987-04-14 | Regents Of The University Of Minnesota | Check valve catheter |
| US5340590A (en) | 1987-06-25 | 1994-08-23 | Alza Corporation | Delivery system with bilayer osmotic engine |
| US5456679A (en) | 1992-02-18 | 1995-10-10 | Alza Corporation | Delivery devices with pulsatile effect |
| US5221278A (en) | 1992-03-12 | 1993-06-22 | Alza Corporation | Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
| ATE195252T1 (de) | 1993-04-23 | 2000-08-15 | Novartis Erfind Verwalt Gmbh | Wirkstoffabgabevorrichtung mit gesteuerter freigabe |
| ZA981610B (en) * | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
| US6436091B1 (en) * | 1999-11-16 | 2002-08-20 | Microsolutions, Inc. | Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
| US8740973B2 (en) * | 2001-10-26 | 2014-06-03 | Icon Medical Corp. | Polymer biodegradable medical device |
| ATE387236T1 (de) | 2003-03-31 | 2008-03-15 | Alza Corp | Osmotische pumpe mit mitteln zum ableiten des innendrucks |
| MXPA06002967A (es) | 2003-09-30 | 2006-06-14 | Alza Corp | Aparato de suministro de agente activo de conduccion osmotica que proporciona perfil de liberacion ascendente. |
| US7455688B2 (en) * | 2004-11-12 | 2008-11-25 | Con Interventional Systems, Inc. | Ostial stent |
| DK1933810T3 (da) | 2005-08-11 | 2013-01-28 | Childrens Medical Center | Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde |
| EP2049081B1 (en) | 2006-08-09 | 2012-11-14 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
| KR101538748B1 (ko) * | 2007-12-11 | 2015-07-22 | 메사추세츠 인스티튜트 오브 테크놀로지 | 이식형 의약 투여 장치와 방광과 기타 신체 낭 또는 내강의 치료 방법 |
| EA201170297A1 (ru) * | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей |
| DK2445570T3 (da) * | 2009-06-26 | 2013-02-25 | Taris Biomedical Inc | Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling |
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| US9017312B2 (en) * | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| US8167836B2 (en) | 2009-12-08 | 2012-05-01 | Taris Biomedical, Inc. | Tissue expander configured for drug delivery |
| PL3884988T3 (pl) | 2009-12-17 | 2025-09-08 | Taris Biomedical Llc | Urządzenie implantowalne z tolerancją wewnątrzpęcherzową |
| US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
| EP3795121A1 (en) * | 2010-08-05 | 2021-03-24 | TARIS Biomedical LLC | Ureteral stent drug delivery device |
| US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
| WO2012048114A1 (en) * | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| JP2014503554A (ja) | 2011-01-10 | 2014-02-13 | タリス バイオメディカル，インコーポレイテッド | 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン |
| EP2670398B1 (en) | 2011-02-04 | 2017-06-07 | TARIS Biomedical LLC | Implantable device for controlled release of low solubility drug |
| CA2872092C (en) * | 2012-04-30 | 2021-02-16 | Taris Biomedical, Inc. | Methods for treatment of pelvic pain and/or comorbid conditions |
| WO2014031676A1 (en) * | 2012-08-20 | 2014-02-27 | O-Ray Pharma, Inc. | Process for manufacturing drug delivery formulations |
| MX379066B (es) * | 2012-09-18 | 2025-03-04 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior. |
| JP2016508842A (ja) * | 2013-03-05 | 2016-03-24 | タリス バイオメディカル エルエルシー | 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法 |
| US9533101B2 (en) | 2013-03-14 | 2017-01-03 | Leonard Allen Massey, JR. | Multi-cycle and auto-disable syringe and method of use thereof |
| KR102557326B1 (ko) * | 2013-03-15 | 2023-07-19 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 구성요소를 가지는 약물 전달 장치 |
| EP2968120B1 (en) * | 2013-03-15 | 2026-01-14 | TARIS Biomedical LLC | Drug delivery devices and methods for drug delivery |
| KR102385603B1 (ko) | 2013-08-19 | 2022-04-11 | 타리스 바이오메디컬 엘엘씨 | 다중 유닛 약물 전달 장치 및 방법 |
| EP3065807A1 (en) * | 2013-11-05 | 2016-09-14 | TARIS Biomedical LLC | Osmotic drug delivery devices, kits, and methods |
| US20170246437A1 (en) * | 2014-09-12 | 2017-08-31 | Taris Biomedical Llc | pH-MODULATING DRUG DELIVERY DEVICES AND METHODS |
| CN104998344A (zh) * | 2015-07-27 | 2015-10-28 | 肖雁冰 | 记忆合金硅胶宫内缓释系统 |
-
2018
- 2018-02-01 PT PT187057864T patent/PT3432970T/pt unknown
- 2018-02-01 WO PCT/US2018/016463 patent/WO2018144738A1/en not_active Ceased
- 2018-02-01 HU HUE18705786A patent/HUE054587T2/hu unknown
- 2018-02-01 EP EP18705786.4A patent/EP3432970B1/en active Active
- 2018-02-01 CN CN201880013473.1A patent/CN110418658A/zh active Pending
- 2018-02-01 PL PL18705786T patent/PL3432970T3/pl unknown
- 2018-02-01 JP JP2019541727A patent/JP7366748B2/ja active Active
- 2018-02-01 AU AU2018217094A patent/AU2018217094B2/en active Active
- 2018-02-01 SI SI201830302T patent/SI3432970T1/sl unknown
- 2018-02-01 SM SM20210310T patent/SMT202100310T1/it unknown
- 2018-02-01 RU RU2019126979A patent/RU2759868C2/ru active
- 2018-02-01 MX MX2019009080A patent/MX2019009080A/es unknown
- 2018-02-01 RS RS20210609A patent/RS62459B1/sr unknown
- 2018-02-01 LT LTEP18705786.4T patent/LT3432970T/lt unknown
- 2018-02-01 US US16/302,061 patent/US11020575B2/en active Active
- 2018-02-01 SG SG11201907033SA patent/SG11201907033SA/en unknown
- 2018-02-01 DK DK18705786.4T patent/DK3432970T3/da active
- 2018-02-01 HR HRP20210571TT patent/HRP20210571T1/hr unknown
- 2018-02-01 KR KR1020197025677A patent/KR102564771B1/ko active Active
- 2018-02-01 ES ES18705786T patent/ES2873084T3/es active Active
-
2019
- 2019-07-31 IL IL268385A patent/IL268385B/en active IP Right Grant
- 2019-07-31 MX MX2024006288A patent/MX2024006288A/es unknown
-
2021
- 2021-05-26 US US17/331,028 patent/US12090292B2/en active Active
- 2021-06-01 CY CY20211100479T patent/CY1124192T1/el unknown
-
2023
- 2023-08-24 AU AU2023219908A patent/AU2023219908B2/en not_active Expired - Fee Related
- 2023-10-11 JP JP2023176139A patent/JP7789045B2/ja active Active
-
2024
- 2024-09-04 US US18/824,361 patent/US20240424269A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124192T1 (el) | Συσκευες για την in vivo χορηγηση φαρμακων | |
| CY1123474T1 (el) | Συσκευες παροχης φαρμακου πολλαπλων μοναδων | |
| MX2020005566A (es) | Dispositivos conectores estabilizadores para acceso vascular y metodos de uso de los mismos. | |
| CO2018010352A2 (es) | Método y aparato para suministro de agentes terapéuticos | |
| CO2017013384A2 (es) | Colocación de un shunt intraocular ab externo | |
| MX2019000403A (es) | Cartucho para un dispositivo de captura de insectos y metodos de este. | |
| EP3496641A4 (en) | DEVICES AND METHOD FOR DELIVERING LIQUID TO TISSUE DURING ABLATION THERAPY | |
| JOP20200220A1 (ar) | أجهزة لحقن أدوية وطرق استخدامها | |
| UY37341A (es) | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada | |
| MX2019006823A (es) | Tratamiento de una enfermedad del tracto gastrointestinal con inhibidor de interleucina-12/interleucina-23 (il-12/il-23) liberado usando un dispositivo ingerible. | |
| MX2017006653A (es) | Metodos para modular los niveles de fármaco en plasma mediante el uso de eritrohidroxibupropión. | |
| WO2015200752A8 (en) | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems | |
| CU20160135A7 (es) | Nanopartículas terapeúticas que comprenden un agente terapéutico y un ácido hidrofóbico, métodos de elaboración y usos de las mismas | |
| CL2021001432A1 (es) | Terapia de combinación de radioinmunoconjugados con inhibidores de daños y reparaciones del adn | |
| EA201690967A1 (ru) | Глазное устройство | |
| MX387283B (es) | Tratamiento del cancer con tg02. | |
| MX2023001963A (es) | Composiciones farmaceuticas hipertonicas que contienen un agente quimioprotector antiplatino. | |
| AR116501A1 (es) | Sistema de suministro de polímero líquido para administración extendida de drogas | |
| ECSP17085443A (es) | Formulación sólida oral que contiene irinotecán y método de preparación de la misma | |
| ES2836537R1 (es) | Dispositivo medico conector | |
| MX2016015343A (es) | Insercion para cateteres de insercion sobre la aguja. | |
| EP4051138A4 (en) | GUIDING DEVICE AND MEDICAL METHOD USING THE GUIDING DEVICE | |
| CL2017001119A1 (es) | Unidad de fármaco-dispositivo que contiene quinagolida | |
| EA201692432A1 (ru) | Способ и устройство для определения времени распадаемости пленочной лекарственной формы | |
| MX2024011521A (es) | Dispositivo de suministro de farmaco. |